Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ozanimod Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111704559A reveals a safer, high-yield route for Ozanimod intermediates, eliminating toxic cyanides and reducing thermal stress in API manufacturing.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Novel preparation method for Ozanimod intermediate offering high purity and scalable manufacturing solutions for pharmaceutical supply chains.